https://www.fda.gov/news-events/press-announcements/fda-approves-interchangeable-biosimilar-multiple-inflammatory-diseases
0
0
10/31/23 at 9:50pm
Organization
FDA.gov
Author
Office of the Commissioner
24 words
0
Comments
The FDA approved Wezlana as an interchangeable biosimilar to Stelara for multiple inflammatory diseases.
You are the first to view
Create an account
or login to join the discussion